Recruiting

Walking Poles

Sponsor:

East Tennessee State University

Code:

NCT07551661

Conditions

PARKINSON DISEASE (Disorder)

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Interventions

Independent walking program using walking poles

Independent walking program without walking poles

Study Details

Brief summary:

Study Purpose: The purpose of the study is to compare changes in walking in people with Parkinson disease after an 8-week independent walking program with or without using walking poles.

Major parts of the Study:

Before the walking program: Measurements will be taken of you while you are walking. You will be given tests and questionnaires about your movement and thinking. You will be trained on how to use walking poles.

Independent walking program: You will be asked to walk at least 3 times each week for 8 weeks and keep a log of your walking. If you are in the walking pole group, you will walk with the poles. After the walking program: Your walking, movement, and thinking measurements will be collected as before the walking program.

Follow-up: The same measures of walking, movement, and thinking will be taken 3-months after ending the walking program.

Conditions

PARKINSON DISEASE (Disorder)

Study ID

NCT07551661

Start date

Apr, 2026

Status verified date

Apr, 2026

Completion date

Jan, 2027

Anticipated

Primary completion date

Oct, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • English-speaking, diagnosis of Parkinson disease, ability to walk safely and independently with or without a cane, and medically cleared to participate in an independent walking program. Participants must be physically present in the USA at the time of assessment.

Exclusion Criteria:

  • diagnosis of any neurological disease other than PD (including but not limited to stroke, dementia, and multiple sclerosis; mild cognitive impairment is not excluded), regular (>30%) use of walking poles during walking for exercise for the prior 6 months, weight of more than 320 pounds or height more than 6'4", unable to participate in walking for more than 7 consecutive days during the study period (ie, traveling, scheduled surgery), anticipated change in Parkinson-specific medication (including additions, removals, or changes in dosage) during the intervention period, a change in deep brain stimulation (DBS) parameters during the intervention.

Study Design

Enrollment

40 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Walking Poles

Participants who will be using walking poles during the independent walking program

active comparator: No Walking Poles

Participants who will not be using walking poles during the independent walking program

Interventions

Independent walking program using walking poles

Participants will independently walk at least 3 times a week for 8 weeks using walking poles

Independent walking program without walking poles

Participants will independently walk at least 3 times a week for 8 weeks without walking poles

Primary outcome measure

  • Six Minute Walk Test [ Time Frame: Prior to initiation of 8 week walking program, immediately upon completion, and 3 months after completion. ]

Central Contacts and Locations

Central contacts

Tiffany Salido, PT, DPT, PhD

423-439-8727salido@etsu.edu

Locations

East Tennessee State University

Recruiting

Johnson City, Tennessee, United States, 37614

Contacts

Tiffany Salido, PT, DPT, PhD

423-439-8727salido@etsu.edu

8284235390salido@etsu.edu

Principal Investigator:

Tiffany Salido, PT, DPT, PhD

More Information

Sponsor

East Tennessee State University

Last update posted

Apr 27, 2026

Last verified

Apr, 2026

Keywords

  • walking
  • physical activity
  • gait
  • Nordic walking
  • arm swing
  • walking poles

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by East Tennessee State University on 2026-04-27.